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Abstract
Introduction: Antiphospholipid (aPL)-mediated endothelial cell
perturbation plays a role in antiphospholipid syndrome
(APS)-associated vasculopathy. It's widely accepted that aPL
antibodies activate endothelium both in vitro and in experimental
animal models by inducing a pro-inflammatory/-coagulant
phenotype. In spite of such large evidence, few contrasting studies
raised the issue about the possibility to detect a comparable
endothelial perturbation ex-vivo in APS patients. The aim of the
study was to evaluate several ex-vivo indirect parameters of
endothelial perturbation in APS patients.
Methods: We investigated plasma levels of soluble adhesion
molecules (sICAM-1, s-VCAM-1, s-E-selectin), soluble
thrombomodulin (sTM), von Willebrand factor (vWF) and tissue
plasminogen activator (t-PA) by solid-phase assays, in 66 APS
patients and 99 age and sex matched healthy subjects. In addition,
circulating endothelial cells identified by flow cytometry and
brachial artery flow mediated vasodilation were evaluated in 38 APS
patients (30 primary APS and 8 SLE-associated APS) and in 47
healthy controls.
Results: We found that plasma levels of circulating TM, t-PA and
VCAM-1 did not differ from controls, while a significant increase in
sICAM-1 (P<0.001), sE-selectin (P<0.001) and vWF titres (P<0.05)
was found. Also circulating mature endothelial cells - with no sign of
activation or undergoing apoptosis - were significantly higher in
patients than in controls, both as percentage of CD146-positive cells
and as absolute number (P<0.05). Furthermore mean brachial artery
flow mediated vasodilation responses were significantly impaired
compared to healthy subjects (P<0.05).
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Conclusions: As a whole these
findings do suggest that aPL
antibodies per se are able to
support a full-blown
endothelial perturbation in
vivo and support the two-hit
hypothesis as suggested by
experimental animal models of
aPL-induced thrombosis.
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